A First Time in Man Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1979 in Healthy Males
Study identifier:D3930C00001
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Terminated/Withdrawn
Official Title
A Phase I, Single-center, Single-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral AZD1979 after Single-ascending Doses in Healthy Male Volunteers
Medical condition
Healthy subjects
Phase
Phase 1
Healthy volunteers
Yes
Study drug
AZD1979, Placebo to match
Sex
Male
Actual Enrollment
56
Study type
Interventional
Age
18 Years - 50 Years
Date
Study Start Date: 01 Mar 2014
Primary Completion Date: 01 Jul 2014
Study Completion Date: 01 Jul 2014
Study design
Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Basic Science
Verification:
Verified 01 Jun 2015 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Experimental: AZD1979 Single ascending doses of oral solution AZD1979 | Drug: AZD1979 Single dose, oral solution administration |
| Placebo Comparator: Placebo Placebo to match single ascending doses of oral solution AZD1979 | Drug: Placebo to match Single dose, oral solution administration |
Contacts
Investigators
Principal Investigator
Eleanor Lisbon
Quintiles 6700 W 115th Street, Overland Park, KS USA
